-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Equal-Weight on Conmed, Raises Price Target to $46

Benzinga·07/30/2026 14:09:40
Listen to the news
Wells Fargo analyst Larry Biegelsen maintains Conmed (NYSE:CNMD) with a Equal-Weight and raises the price target from $39 to $46.